Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 DOI Open Access
Issam Ben‐Sahra, Jessica J. Howell, John M. Asara

и другие.

Science, Год журнала: 2013, Номер 339(6125), С. 1323 - 1328

Опубликована: Фев. 22, 2013

Coordinating Metabolism Growth factors help to coordinate metabolism with growth in part by stimulating the activity of protein kinase mTORC1 (mechanistic target rapamycin complex 1). Ben-Sahra et al. (p. 1323 , published online 21 February) and Robitaille 1320 independently identified a key mTORC1—carbamolyl-phosphate synthase 2, or CAD, rate-limiting enzyme for de novo synthesis pyrimidines. Metabolomic profiling phosphoproteomic analyses normal cells lacking signaling converged on CAD as point at which growth-promoting signals also ramp up production nucleic acids.

Язык: Английский

mTOR Signaling in Growth Control and Disease DOI Creative Commons
Mathieu Laplante, David M. Sabatini

Cell, Год журнала: 2012, Номер 149(2), С. 274 - 293

Опубликована: Апрель 1, 2012

Язык: Английский

Процитировано

7814

mTOR Signaling in Growth, Metabolism, and Disease DOI Creative Commons
Robert A. Saxton, David M. Sabatini

Cell, Год журнала: 2017, Номер 168(6), С. 960 - 976

Опубликована: Март 1, 2017

Язык: Английский

Процитировано

6377

AKT/PKB Signaling: Navigating the Network DOI Creative Commons
Brendan D. Manning, Alex Toker

Cell, Год журнала: 2017, Номер 169(3), С. 381 - 405

Опубликована: Апрель 1, 2017

Язык: Английский

Процитировано

3066

Mechanisms of Insulin Action and Insulin Resistance DOI Open Access
Max C. Petersen, Gerald I. Shulman

Physiological Reviews, Год журнала: 2018, Номер 98(4), С. 2133 - 2223

Опубликована: Авг. 1, 2018

The 1921 discovery of insulin was a Big Bang from which vast and expanding universe research into action resistance has issued. In the intervening century, some discoveries have matured, coalescing solid fertile ground for clinical application; others remain incompletely investigated scientifically controversial. Here, we attempt to synthesize this work guide further mechanistic investigation inform development novel therapies type 2 diabetes (T2D). rational such necessitates detailed knowledge one key pathophysiological processes involved in T2D: resistance. Understanding resistance, turn, requires normal action. review, both physiology pathophysiology are described, focusing on three target tissues: skeletal muscle, liver, white adipose tissue. We aim develop an integrated physiological perspective, placing intricate signaling effectors that carry out cell-autonomous response context tissue-specific functions generate coordinated organismal response. First, section II, effects direct, tissue reviewed, beginning at receptor working downstream. Section III considers critical underappreciated role crosstalk whole body action, especially essential interaction between lipolysis hepatic gluconeogenesis. is then described IV. Special attention given pathways become resistant setting chronic overnutrition, alternative explanation phenomenon ‟selective resistanceˮ presented. Sections V, VI, VII critically examine evidence against several putative mediators V reviews linking bioactive lipids diacylglycerol, ceramide, acylcarnitine resistance; VI impact nutrient stresses endoplasmic reticulum mitochondria discusses non-cell autonomous factors proposed induce including inflammatory mediators, branched-chain amino acids, adipokines, hepatokines. Finally, VIII, propose model links these final common metabolite-driven gluconeogenesis ectopic lipid accumulation.

Язык: Английский

Процитировано

2251

The PI3K Pathway in Human Disease DOI Creative Commons
David A. Fruman, Honyin Chiu, Benjamin D. Hopkins

и другие.

Cell, Год журнала: 2017, Номер 170(4), С. 605 - 635

Опубликована: Авг. 1, 2017

Язык: Английский

Процитировано

2207

mTOR at the nexus of nutrition, growth, ageing and disease DOI
Grace Y. Liu, David M. Sabatini

Nature Reviews Molecular Cell Biology, Год журнала: 2020, Номер 21(4), С. 183 - 203

Опубликована: Янв. 14, 2020

Язык: Английский

Процитировано

2101

Mass-spectrometric exploration of proteome structure and function DOI
Ruedi Aebersold, Matthias Mann

Nature, Год журнала: 2016, Номер 537(7620), С. 347 - 355

Опубликована: Сен. 1, 2016

Язык: Английский

Процитировано

1919

The functions and regulation of the PTEN tumour suppressor DOI

Min Sup Song,

Leonardo Salmena, Pier Paolo Pandolfi

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2012, Номер 13(5), С. 283 - 296

Опубликована: Апрель 4, 2012

Язык: Английский

Процитировано

1829

mTOR: a pharmacologic target for autophagy regulation DOI Open Access
Young Chul Kim, Kun‐Liang Guan

Journal of Clinical Investigation, Год журнала: 2015, Номер 125(1), С. 25 - 32

Опубликована: Янв. 1, 2015

mTOR, a serine/threonine kinase, is master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to wide range cues, its signaling pathway deregulated many human diseases. also plays crucial role regulating autophagy. This Review provides an overview the pathway, mechanisms autophagy regulation, clinical implications inhibitors disease treatment.

Язык: Английский

Процитировано

1772

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB DOI
Carmine Settembre, Roberto Zoncu, Diego L. Medina

и другие.

The EMBO Journal, Год журнала: 2012, Номер 31(5), С. 1095 - 1108

Опубликована: Фев. 17, 2012

Язык: Английский

Процитировано

1740